Rare Disease

Exploring What’s Possible for HS Treatment
October 22, 2022

At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.

How Spesolimab Will Revolutionize Generalized Pustular Psoriasis Flares Treatment
October 21, 2022

Aaron Farberg, MD, presents study data and efficacy of spesolimab for the treatment of generalized pustular psoriasis at the 2022 Fall Clinical Dermatology Conference.

What's New and Hot in Infectious Disease
October 21, 2022

At the 2022 Fall Clinical Dermatology Conference, a look at the latest treatments for monkeypox, HIV, and more.

A Close Look at Necrobiosis Lipoidica
October 19, 2022

How to diagnose and treat this rare skin disorder.

Study Suggests Significant Unmet Need in Current GPP Treatment
October 14, 2022

Patients with generalized pustular psoriasis flares were 2 times more likely to have emergency department visits.

Preventing Misdiagnosis of Rare Skin Diseases
October 01, 2022

Thorough history taking is essential during the consultation and can help clinicians rule out other potential differential diagnoses.

POLL: How Many People in the US Have Generalized Pustular Psoriasis?
September 26, 2022

Click here to answer this week's poll.

Adjuvant Treatment With Nivolumab Shows Positive Results in Phase 3 Trial
September 16, 2022

Bristol Myers Squibb’s nivolumab shows potential for treatment in earlier stages of melanoma.

Timber Pharmaceuticals Presents CI Study Data at EADV Congress
September 08, 2022

TMB-001 showed positive results in the reduction of congenital ichthyosis severity in a phase 2b CONTROL study.

FDA Approves Spesolimab-Sbzo Injection for GPP Flares
September 02, 2022

Boehringer Ingelheim’s first treatment option for adults will help manage burdensome flares.